2012, Palliative nursing and Presentation - Home Care & Hospice Network

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2012

Palliative nursing

Presentation

Undisclosed Conflicts of Interest by Physicians Creating the CDC Opioid Prescribing Guidelines: Bad Faith or Incompetence?

Pallimed

SEPTEMBER 12, 2022

PROP and Chou petitioned the Food and Drug Administration (FDA) to change opioid labeling in July 2012 (29, 30), but FDA rejected PROP’s call for a maximum daily dose of opioid analgesia of 100 morphine milligram equivalents (MME) based on a lack of supporting data (31). New York Times, February 2012 (updated February 9, 2016).

2016

2016 2019 2022 2015

PROP’s Disproportionate Influence on U.S. Opioid Policy: The Harms of Intended Consequences

Pallimed

MAY 3, 2021

PROP Petition to the FDA on Opioid Labeling The Petition is Filed In its first effort to influence national opioid policy, in July 2012, PROP submitted a Petition to the Food and Drug Administration (FDA) calling for a change in labeling of opioid analgesics (8).

2016

2016 2019 2015 Article

Undisclosed Conflicts of Interest by Physicians Creating the CDC Opioid Prescribing Guidelines: Bad Faith or Incompetence?

PROP’s Disproportionate Influence on U.S. Opioid Policy: The Harms of Intended Consequences

Stay Connected